Metandienone 10

Metandienone is contraindicated in patients with:

• Hypersensitivity to metandienone or any of its components
• Pregnancy or breastfeeding
• Prostate or breast cancer
• Nephrosis (the nephrotic phase of nephritis)
• Hypercalcemia
• Severe hepatic dysfunction

Caution is advised in patients with a history of cardiac, hepatic, or renal disease.

It is important to note that the use of metandienone, like other anabolic steroids, carries risks and potential side effects that require close medical supervision. Patients should be monitored for any adverse reactions, including those related to liver function.

The recommended adult dosage of metandienone ranges from 2.5 mg to 20 mg daily in 2 to 4 divided doses. Treatment courses typically last 2 to 4 weeks and may be repeated intermittently as needed. Dosage should be individualized based on the patient’s response and tolerability.

Metandienone is a controlled substance and has the potential for abuse. It should be used only as prescribed under medical supervision.